Department of Medical and Surgical Sciences, Institute of Respiratory Diseases, University of Foggia, Italy.
Department of Medical and Surgical Sciences, Institute of Respiratory Diseases, University of Foggia, Italy.
Pulm Pharmacol Ther. 2017 Oct;46:64-68. doi: 10.1016/j.pupt.2017.08.009. Epub 2017 Aug 17.
There is no evidence in the literature regarding the combined use of positive ventilation with negative ventilation. A recent study reported that the two techniques can be combined in patients with ARDS, who undergo ventilatory support for severe acute respiratory failure (ARF). There is experience of non-invasive ventilation in patients with chronic respiratory diseases and ARF. The aim of this study was to test the efficacy of a non-invasive ventilatory strategy based on the combined use of negative (N) and positive ventilation (P) in bi-level mode (PN).
We enrolled 8 patients with severe COPD exacerbations and exacerbated chronic respiratory failure admitted in a monitored setting of an intermediate-intensive respiratory Unit.
Patients underwent combined positive/negative ventilation and at different times, in place of the two singular ventilation modes (P and N). After each cycle, in the combined P/N ventilatory mode, gas exchanges were significantly increased compared to the two singular P/N mode: pH (7.42 vs 7.40 and 7.40); PCO2 (85.01 vs 72.05 and 66.81 mmHg); FiO2/PO2 (488.75 vs 352.62 and 327.87). All patients well tolerated the application of the double ventilation mode.
In conclusion, the use of dual mode ventilation appears well tolerated and superior to the individual modes in patients with COPD exacerbations and ARF.
目前尚无文献报道正压通气与负压通气联合使用的情况。最近的一项研究报告称,这两种技术可联合用于因严重急性呼吸衰竭(ARF)而接受通气支持的 ARDS 患者。对于慢性呼吸疾病和 ARF 患者,已经有使用无创通气的经验。本研究旨在测试基于双水平模式(PN)下联合使用负压(N)和正压通气(P)的无创通气策略的疗效。
我们招募了 8 名患有严重 COPD 加重和加重性慢性呼吸衰竭的患者,这些患者在中级重症呼吸病房的监测环境中接受治疗。
患者接受了联合正/负压通气,并在不同时间替代了两种单一通气模式(P 和 N)。在联合 P/N 通气模式的每个周期后,与两种单独的 P/N 通气模式相比,气体交换明显增加:pH(7.42 与 7.40 和 7.40);PCO2(85.01 与 72.05 和 66.81mmHg);FiO2/PO2(488.75 与 352.62 和 327.87)。所有患者均能很好地耐受双通气模式的应用。
总之,在 COPD 加重和 ARF 患者中,双模式通气的应用耐受性良好,优于单一通气模式。